VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
for Head and Neck Carcinoma
14 locations incl. Santa Rosa
Sponsor: VM Oncology, LLC
Sex: All·Age: 18 - 80
Code: NCT03556228·Phase 1, Phase 2·Recruiting